ANNABELLE TOUPONCE: Open Payments
NPI 1861979361 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $241 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Lundbeck LLC | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: VRAYLAR, REXULTI, CAPLYTA.
Industry payments across CA — which companies pay providers there.
